The Board of Directors of the Emirates Drug Establishment مؤسسة الإمارات للدواء (EDE) has wrapped up its annual meetings for 2024 with a session outlining this year’s key achievements and evaluating progress on its strategic goals for the 2024-2026 period. Read More: https://lnkd.in/dmHRc_y9 Chaired by Dr. Thani Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Emirates Drug Establishment, the meeting was attended by H.E. Dr. Maha Taysir Barakat, Vice Chairman of EDE’s Board of Directors, and H.E. Dr. Fatima Alkaabi, EDE Director General. Also present were board members, including H.E. Dr. Essa Abdulfattah Kazim, H.E Badr Al-Olama, H.E. Dr.Amer Sharif H.E. Dr. Farhan Malak, and Professor Chris Evans. For her part, H.E. Dr. Fatima Al Kaabi, stressed that the establishment will continue to develop and execute strategic plans to fulfil its ambitious goals. “We’ve made great progress in advancing our structure and strengthening research partnerships that would help improve the quality of life for our community and contribute to sustainable economic growth,” she said. #mededgemea #PharmaceuticalInnovation #HealthcareLeadership #Sustainability #InnovationInMedicine
